Product Information Update – Hypovase 0.5 mg tablets (PA0822/195/001)

Notice type: 3rd Party Publications

Date: 08/03/2024

This update is to inform healthcare professionals of a recent update to the product information for Hypovase 0.5 mg tablets, (prazosin hydrochloride). This update relates to the deletion all indications of paediatric use of prazosin in the Summary of Product Characteristics and Patient Information Leaflet.

Please see the document linked below for further information.

Product name or type:
Hypovase 0.5 mg tablets, (prazosin hydrochloride) PA0822/195/001

Authorisation Holder:

Pfizer Healthcare Ireland

Further Information:

Product Information Update – Hypovase 0.5mg tablets – 16 February 2024

« Back